Yakushiji M, Kato T
Department of Obstetrics and Gynecology, Kurume University School of Medicine, Japan.
Semin Surg Oncol. 1986;2(2):72-5. doi: 10.1002/ssu.2980020203.
One hundred and thirty four patients had a second-look laparotomy in the course of management of cancer of the ovary. Patients were stratified according to four indications: (1) resection of the residual tumor following chemotherapy or radiation therapy, (2) evaluation of the disease with intent to stop chemotherapy and assess signs of recurrence or persistence, (3) restaging, and (4) surgical indication. The first group consisted of 35 patients. In 20 of 35 patients in this group, complete removal of the residual tumor (residual less than or equal to 2 cm) was possible, and the survival curves indicated that removal of the residual tumor during the second-look laparotomy improved the survival rate. The second group consisted of 77 patients. No evidence of disease was found in 44 of the 77 patients in this group. Four patients with negative second-look laparotomy developed recurrences, and three patients died from the disease. The third group consisted of seven patients. In one of seven patients in this group, the stage was modified after second-look laparotomy.
134例卵巢癌患者在治疗过程中接受了二次剖腹探查术。患者根据四种指征进行分层:(1)化疗或放疗后切除残留肿瘤;(2)评估疾病情况,意图停止化疗并评估复发或持续的迹象;(3)重新分期;(4)手术指征。第一组包括35例患者。该组35例患者中有20例能够完全切除残留肿瘤(残留小于或等于2厘米),生存曲线表明在二次剖腹探查术中切除残留肿瘤可提高生存率。第二组包括77例患者。该组77例患者中有44例未发现疾病证据。二次剖腹探查术结果为阴性的4例患者出现复发,3例患者死于该疾病。第三组包括7例患者。该组7例患者中有1例在二次剖腹探查术后分期得到修正。